164 related articles for article (PubMed ID: 25667327)
41. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
42. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
[TBL] [Abstract][Full Text] [Related]
43. Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.
Laidlaw SM; Marukian S; Gilmore RH; Cashman SB; Nechyporuk-Zloy V; Rice CM; Dustin LB
Gastroenterology; 2017 Aug; 153(2):566-578.e5. PubMed ID: 28456632
[TBL] [Abstract][Full Text] [Related]
44. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures.
Ploss A; Khetani SR; Jones CT; Syder AJ; Trehan K; Gaysinskaya VA; Mu K; Ritola K; Rice CM; Bhatia SN
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3141-5. PubMed ID: 20133632
[TBL] [Abstract][Full Text] [Related]
45. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
46. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
Colpitts CC; Tsai PL; Zeisel MB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197477
[TBL] [Abstract][Full Text] [Related]
48. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
49. HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.
Narbus CM; Israelow B; Sourisseau M; Michta ML; Hopcraft SE; Zeiner GM; Evans MJ
J Virol; 2011 Nov; 85(22):12087-92. PubMed ID: 21917968
[TBL] [Abstract][Full Text] [Related]
50. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
51. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
52. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
53. Studying HCV cell entry with HCV pseudoparticles (HCVpp).
Bartosch B; Cosset FL
Methods Mol Biol; 2009; 510():279-93. PubMed ID: 19009269
[TBL] [Abstract][Full Text] [Related]
54. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
Martin DN; Uprichard SL
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus entry: potential receptors and their biological functions.
Cocquerel L; Voisset C; Dubuisson J
J Gen Virol; 2006 May; 87(Pt 5):1075-1084. PubMed ID: 16603507
[TBL] [Abstract][Full Text] [Related]
56. The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.
Hoffmann TW; Delfosse F; Helle F; François C; Duverlie G; Castelain S
Arch Virol; 2014 Mar; 159(3):527-34. PubMed ID: 24100473
[TBL] [Abstract][Full Text] [Related]
57. Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry.
Matsumura T; Hu Z; Kato T; Dreux M; Zhang YY; Imamura M; Hiraga N; Juteau JM; Cosset FL; Chayama K; Vaillant A; Liang TJ
Gastroenterology; 2009 Aug; 137(2):673-81. PubMed ID: 19394333
[TBL] [Abstract][Full Text] [Related]
58. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
[TBL] [Abstract][Full Text] [Related]
59. Persistent hepatitis C virus infection in vitro: coevolution of virus and host.
Zhong J; Gastaminza P; Chung J; Stamataki Z; Isogawa M; Cheng G; McKeating JA; Chisari FV
J Virol; 2006 Nov; 80(22):11082-93. PubMed ID: 16956932
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration.
Bürgel B; Friesland M; Koch A; Manns MP; Wedemeyer H; Weissenborn K; Schulz-Schaeffer WJ; Pietschmann T; Steinmann E; Ciesek S
J Viral Hepat; 2011 Aug; 18(8):562-70. PubMed ID: 20579278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
